The role of obstetrician/gynecologists in the management of hepatitis C virus infection

Infectious Diseases in Obstetrics and Gynecology

Volumn 2008, Issue , 2008, Pages

  Gonik, Bernard ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN;

BONE MARROW SUPPRESSION; DEPRESSION; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; EMOTIONAL DISORDER; ENZYME IMMUNOASSAY; GENOTYPE; GYNECOLOGY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MEDICAL PRACTICE; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEXUAL TRANSMISSION; TREATMENT DURATION; VIRUS TRANSMISSION; COUNSELING; DISEASE TRANSMISSION; FEMALE; HEPATITIS C VIRUS; OBSTETRICS; PHYSICIAN ATTITUDE; PREGNANCY COMPLICATION; VIROLOGY;

COUNSELING; FEMALE; GYNECOLOGY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; OBSTETRICS; PHYSICIAN'S ROLE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 54249148090     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2008/374517     Document Type: Review

References (39)

1. Centers for Disease Control and Prevention, Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease Morbidity And Mortality Weekly Report 1998 47 RR19 1 39
2. Armstrong G. L., Wasley A., Simard E. P., McQuillan G. M., Kuhnert W. L., Alter M. J., The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Annals of Internal Medicine 2006 144 10 705 714
3. National Institutes of Health (NIH), Management of hepatitis C: 2002. NIH Consensus State-of-the-Science Statement, 1-28, 2002, http://consensus.nih.gov/ 2002/2002HepatitisC2002116html.htm
4. World Health Organization, Hepatitis C. Epidemic and Pandemic Alert and Response. 2002, http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/ index.html
5. Dienstag J. L., Isselbacher K. J., Kaspar D. L., Fauci A. S., Longo D. L., Braunwald E., Hauser S. L., Jameson J. L., Acute viral hepatitis Harrison's Principles of Internal Medicine 2005 16th chapter 285 New York, NY, USA McGraw-Hill 1822 1838
6. Alter M. J., Seeff L. B., Bacon B. R., Thomas D. L., Rigsby M. O., Di Bisceglie A. M., Testing for hepatitis C virus infection should be routine for persons at increased risk for infection Annals of Internal Medicine 2004 141 9 715 717
7. Poynard T., Mathurin P., Lai C.-L., A comparison of fibrosis progression in chronic liver diseases Journal of Hepatology 2003 38 3 257 265
8. Kim W. R., The burden of hepatitis C in the United States Hepatology 2002 36 5B S30 S34
9. Thorpe L. E., Ouellet L. J., Hershow R., Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment American Journal of Epidemiology 2002 155 7 645 653
10. Diaz T., Des Jarlais D. C., Vlahov D., Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City American Journal of Public Health 2001 91 1 23 30
11. Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E., Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses American Journal of Public Health 1996 86 5 655 661
12. Strader D. B., Wright T., Thomas D. L., Seeff L. B., AASLD practice guideline. Diagnosis, management, and treatment of hepatitis C Hepatology 2004 39 4 1147 1171
13. Alter M. J., Epidemiology of hepatitis C Hepatology 1997 26 3, supplement 1 62S 65S
14. Meisel H., Reip A., Faltus B., Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin The Lancet 1995 345 8959 1209 1211
15. Vandelli C., Renzo F., Romanò L., Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study The American Journal of Gastroenterology 2004 99 5 855 859
16. Kao J.-H., Liu C.-J., Chen P.-J., Chen W., Lai M.-Y., Chen D.-S., Low incidence of hepatitis C virus transmission between spouses: a prospective study Journal of Gastroenterology and Hepatology 2000 15 4 391 395
17. Neumayr G., Propst A., Schwaighofer H., Judmaier G., Vogel W., Lack of evidence for the heterosexual transmission of hepatitis C QJM 1999 92 9 505 508
18. Brettler D. B., Mannucci P. M., Gringeri A., The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophiliac males: an international multicenter study Blood 1992 80 2 540 545
19. Terrault N. A., Sexual activity as a risk factor for hepatitis C Hepatology 2002 36 5B S99 S105
20. Marx M. A., Murugavel K. G., Tarwater P. M., Association of hepatitis C virus infection with sexual exposure in southern India Clinical Infectious Diseases 2003 37 4 514 520
21. Gambotti L., Batisse D., Colin-de-Verdiere N., Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004 Euro Surveillance 2005 10 5 115 117
22. Conry-Cantilena C., VanRaden M., Gibble J., Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection The New England Journal of Medicine 1996 334 26 1691 1696
23. Centers for Disease Control and Prevention, Workowski K. A., Berman S. M., Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines 2006 Morbidity And Mortality Weekly Report 2006 55 RR-11 69 76
24. Puro V., Petrosillo N., Ippolito G., Risk of hepatitis C seroconversion after occupational exposures in health care workers American Journal of Infection Control 1995 23 5 273 277
25. Alter M. J., Healthcare should not be a vehicle for transmission of hepatitis C virus Journal of Hepatology 2008 48 1 2 4
26. Centers for Disease Control and Prevention, Viral Hepatitis Transmission in Ambulatory Health Care Settings. http://www.cdc.gov/ncidod/diseases/ hepatitis/spotlights/ambulatory.htm
27. Alter M. J., Epidemiology of hepatitis C in the West Seminars in Liver Disease 1995 15 1 5 14
28. Ackerman Z., Ackerman E., Paltiel O., Intrafamilial transmission of hepatitis C virus: a systematic review Journal of Viral Hepatitis 2000 7 2 93 103
29. Dienstag J. L., McHutchison J. G., American gastroenterological association medical position statement on the management of hepatitis C Gastroenterology 2006 130 1 225 230
30. Poynard T., McHutchison J., Manns M., Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 2002 122 5 1303 1313
31. Swain M. G., Lai M.-Y., Shiffman M. L., Durable sustained virological response after treatment with peginterferon α -2a (PEGASYS ®) or in combination with ribavarin (COPEGUS ®): 5-year follow-up and the criteria of a cure Journal of Hepatology 2006 46 supplement 1 S3
32. PEGASYS ® (peginterferon alfa-2a) package insert. Hoffman-La Roche Inc, Nutley, NJ, USA, May 2007
33. Poynard T., Bedossa P., Opolon P., Natural history of liver fibrosis progression in patients with chronic hepatitis C The Lancet 1997 349 9055 825 832
34. Wong T., Lee S. S., Hepatitis C: a review for primary care physicians Canadian Medical Association Journal 2006 174 5 649 659
35. Beers M. H., Robert Berkow R., Chronic hepatitis The Merck Manual of Diagnosis and Therapy 2004 chapter 27 Whitehouse Station, NJ, USA Merck Research Laboratories
36. Corrao G., Aricò S., Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis Hepatology 1998 27 4 914 919
37. Westin J., Lagging L. M., Spak F., Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection Journal of Viral Hepatitis 2002 9 3 235 241
38. Vento S., Garofano T., Renzini C., Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C The New England Journal of Medicine 1998 338 5 286 290
39. Fuller C. M., Ompad D. C., Galea S., Wu Y., Koblin B., Vlahov D., Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City Journal of Urban Health 2004 81 1 20 24